Prediabetes and Type II Diabetes

According to published studies, individuals with type 2 diabetes or prediabetes who followed a genetically-guided diet based on polygenic risk assessment¹ experienced faster and more effective improvements in glycemic control compared to those who did not have access to genetic information.

The GENOSOPHY® Genetic Test analyzes over 60 diabetes-related genetic variants and simultaneously evaluates obesity risk (via 93 additional variants), offering valuable guidance for personalized disease management.

Who Should Consider This Test?

This test is recommended for:
• Individuals diagnosed with type 2 diabetes or prediabetes
• Those seeking precision nutrition strategies to optimize glycemic control

Clinical Benefits of the GENOSOPHY® Polygenic Risk Score

Diagnosis

Identification of individuals with increased genetic risk for type 2 diabetes

Enables targeted medical monitoring and early intervention

Management

• Development of personalized nutrition, exercise, and supplement strategies based on an individual’s genetic profile
• Enhances adherence and effectiveness of Medical Nutrition Therapy (MNT)

Test Procedure

1. Saliva sample collection
2. Analysis of >153 genetic variants using the award-winning GENOSOPHY® algorithm
3. Results delivered in 5–6 weeks

Complementary Services

Based on individual test results and genetic profile, GENOSOPHY® offers the following services to maximize intervention success:
• Genetic counseling
• Personalized nutrition plan
• Targeted dietetic consultation

Key Reference

Gkouskou KK, Grammatikopoulou MG, Lazou E, Sanoudou D, Goulis DG, Eliopoulos AG. Genetically-Guided Medical Nutrition Therapy in Type 2 Diabetes Mellitus and Pre-diabetes: A Series of n-of-1 Superiority Trials. Front Nutr. 2022;9.

DOI: 10.3389/fnut.2022.849723